Breast Radiotherapy: Less is More?

被引：25

作者：

Coles, C. E. ^{[1
]}

Brunt, A. M. ^{[2
]}

Wheatley, D. ^{[3
]}

Mukesh, M. B. ^{[1
]}

Yarnold, J. R. ^{[4
,5
]}

机构：

[1] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England

[2] Univ Hosp N Staffordshire NHS Trust, Stoke On Trent, Staffs, England

[3] Royal Cornwall Hosp NHS Trust, Truro, England

[4] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[5] Inst Canc Res, Sutton, Surrey, England

来源：

CLINICAL ONCOLOGY | 2013年 / 25卷 / 02期

基金：

英国医学研究理事会;

关键词：

Breast cancer; clinical trials; radiotherapy; TARGETED INTRAOPERATIVE RADIOTHERAPY; CONSERVING THERAPY; WHOLE-BREAST; HYPOFRACTIONATED RADIOTHERAPY; UK STANDARDIZATION; RADIATION-THERAPY; SURGICAL CLIPS; DOSE-RESPONSE; NORMAL TISSUE; CANCER;

D O I：

10.1016/j.clon.2012.10.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A 3 week schedule of whole breast radiotherapy is firmly established in the UK and is becoming more accepted internationally, especially as accelerated partial breast radiotherapy regimens become more common. It seems that a 3 week schedule is unlikely to be the lower limit of whole breast hypofractionation and the partial breast may even be adequately treated with just a single treatment. It is, however, essential that these hypotheses are rigorously tested within well-designed trials to ensure the highest quality of radiotherapy. This overview will address the rationale for hypofractionation in breast cancer, discuss past trials and outline the design of current studies. (c) 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：127 / 134

页数：8

共 50 条

[1] Partial breast irradiation: when less could be more
Alvim Ambrosio, Alexandre Vasconcellos
Melo Gondim, Guilherme Rocha
Inocente Inacio, Murilo Jose
de Assis Pellizzon, Antonio Cassio
TRANSLATIONAL CANCER RESEARCH, 2020, 9 : S56 - S61
[2] Hypofractionated breast radiotherapy: Financial and economic consequences
Lievens, Yolande
BREAST, 2010, 19 (03) : 192 - 197
[3] Breast radiotherapy for ductal carcinoma in situ: could less be more?
Coles, Charlotte E.
Chatterjee, Sanjoy
Jagsi, Reshma
Kirby, Anna M.
LANCET, 2022, 400 (10350) : 408 - 410
[4] Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects
Yarnold, John
Haviland, Joanne
ACTA ONCOLOGICA, 2010, 49 (08) : 1288 - 1292
[5] Contribution of Magnetic Resonance Imaging in Determining Lumpectomy Cavity in Breast Radiotherapy
Demircioglu, Ozlem
Tepetam, Huseyin
Eren, Ayfer Ay
Ozgen, Zerrin
Demircioglu, Fatih
Aribal, Erkin
CURRENT MEDICAL IMAGING, 2020, 16 (08) : 997 - 1003
[6] Breast cancer surgery: when less is more
Mannell, A.
SOUTH AFRICAN JOURNAL OF SURGERY, 2019, 57 (01) : 2 - 6
[7] Trastuzumab and Hypofractionated Whole Breast Radiotherapy: A Victorious Combination?
De Santis, Maria Carmen
Bonfantini, Francesca
Di Salvo, Francesca
Fiorentino, Alba
Riboldi, Valentina Maria
Di Cosimo, Serena
Bianchi, Giulia Valeria
Gennaro, Massimiliano
Cosentino, Vito
Sant, Milena
Pignoli, Emanuele
Valdagni, Riccardo
Lozza, Laura
CLINICAL BREAST CANCER, 2018, 18 (03) : E363 - E371
[8] Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?
Colciago, Riccardo Ray
Cavallo, Anna
Magri, Maria Chiara
Vitullo, Angelo
La Rocca, Eliana
Giandini, Carlotta
Bonfantini, Francesca
Di Cosimo, Serena
Baili, Paolo
Sant, Milena
Pignoli, Emanuele
Valdagni, Riccardo
Lozza, Laura
De Santis, Maria Carmen
MEDICAL ONCOLOGY, 2021, 38 (09)
[9] Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
Koukourakis, Ioannis M.
Panteliadou, Marianthi
Giakzidis, Axiotis G.
Nanos, Christos
Abatzoglou, Ioannis
Giatromanolaki, Alexandra
Koukourakis, Michael I.
CURRENT ONCOLOGY, 2021, 28 (05) : 3474 - 3487
[10] Hypofractionation in adjuvant breast radiotherapy
Khan, Atif
Haffty, Bruce G.
BREAST, 2010, 19 (03) : 168 - 171

← 1 2 3 4 5 →